Andrea Schmid

Rindopepimut with temozolomide for patients with newly diagnosed, EGFRvIII-expressing glioblastoma (ACT IV): a randomised, double-blind, international phase 3 trial

Michael Weller, Nicholas Butowski, David Tran et al. · The Lancet Oncology · 2017 · 1.1K citations

Egfrviii-expressing Glioblastoma, Neuro-oncology, Act Iv +10

Bevacizumab plus hypofractionated radiotherapy versus radiotherapy alone in elderly patients with glioblastoma: the randomized, open-label, phase II ARTE trial

Hans‐Georg Wirsching, Ghazaleh Tabatabai, Ulrich Roelcke et al. · Annals of Oncology · 2018 · 85 citations · Full text

Role of plerixafor in autologous stem cell mobilization with vinorelbine chemotherapy and granulocyte-colony stimulating factor in patients with myeloma: a phase II study (PAV-trial)

Andrea Schmid, Dorothea Friess, Behrouz Mansouri Taleghani et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2014 · 17 citations

Immunology, Phase Ii Study, Myeloid Neoplasia +19

IMA901 Multipeptide Vaccine Randomized International Phase III Trial (IMPRINT): A randomized, controlled study investigating IMA901 multipeptide cancer vaccine in patients receiving sunitinib as first-line therapy for advanced/metastatic RCC.

Brian I. Rini, Tim Eisen, A. Stenzl et al. · Journal of Clinical Oncology · 2011 · 16 citations